glp-1 shortage news november 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 ISPOR 2025: Exploring reasons for

For a patient on metformin and insulin degludec who cannot use GLP-1 receptor agonists due to pancreatitis history, add an SGLT2 inhibitor with proven cardio...

Considering coming off Ozempic cold turkey

GLP-1 receptor agonists, which mimic the hormone Glucagon-Like Peptide-1, are transforming treatment for diabetes and obesity

All of these unanswered questions only add to the urgency of determining who is most likely to benefit from GLP-1s. : Luliia Burmistrova / Getty

Weight-loss drugs like Ozempic are in shortage, and telehealth startups are selling compounded versions

And when youre on a GLP-1 receptor agonist, your nutritional strategy is more important than ever